FRUSCIO ROBERT

Katona, B., Lubinski, J., Pal, T., Huzarski, T., Foulkes, W., Moller, P., et al. (2025). The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation. CANCER, 131(1 (1 January 2025)) [10.1002/cncr.35666]. Detail

Loizzi, V., Comes, M., Arezzo, F., Apostol, A., Bove, S., Fanizzi, A., et al. (2025). Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy. FRONTIERS IN ONCOLOGY, 15 [10.3389/fonc.2025.1574037]. Detail

Bianchi, T., Grassi, T., De Ponti, E., Pecis Cavagna, G., Bombelli, M., Lugotti, D., et al. (2025). Postoperative Complications After Cytoreductive Surgery for Advanced Ovarian Carcinoma: A Single-Center Analysis Exploring the Value of the Comprehensive Complication Index and the Predictors of High Complications Burden. ANNALS OF SURGICAL ONCOLOGY, 32(9), 6604-6615 [10.1245/s10434-025-17619-9]. Detail

Boria, F., Chacón, E., Iyer, R., Fanfani, F., Falcone, F., Bretová, P., et al. (2025). Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(5 (May 2025)) [10.1016/j.ijgc.2025.101771]. Detail

Cioffi, R., Fruscio, R., Sabetta, G., Bergamini, A., Dell'Oro, C., Scarfone, G., et al. (2025). Consolidation courses in low-risk gestational trophoblastic neoplasia and relapse rate: A MITO-9 retrospective study. GYNECOLOGIC ONCOLOGY, 196(May 2025), 54-58 [10.1016/j.ygyno.2025.03.033]. Detail